Eyeworld

JUL 2017

EyeWorld is the official news magazine of the American Society of Cataract & Refractive Surgery.

Issue link: https://digital.eyeworld.org/i/842895

Contents of this Issue

Navigation

Page 51 of 138

49 EW FEATURE July 2017 • MIGS roundup Nguyen: nguyen.quang@scrippshealth.org Sarkisian: steven-sarkisian@dmei.org Another possible complication is a higher IOP right after insertion, Dr. Craven said. "This happens in patients with more significant glaucoma. It usually gets better with patient observation. Use aqueous suppressants and steroids and wait," he advised. Bleeding and a low IOP are pos- sible but are fairly uncommon, Dr. Flowers added. Options for cataract surgeons Cataract surgeons should be pre- pared to have a microinvasive glaucoma surgery (MIGS) approach they can use, said the surgeons in- terviewed by EyeWorld. "You can't afford to not have a MIGS procedure in your armamen- tarium," Dr. Sarkisian said. "The learning curve for the CyPass is rea- sonably short, and once a surgeon has gotten over that, the opportuni- ty to use the CyPass will avail itself frequently." One other advantage that Dr. Nguyen sees is the opportunity to intervene earlier in the course of glaucoma and offer better IOP con- trol, with the possibility of reducing glaucoma medications. "From a technical standpoint, it's doable. If you can do phaco, which is a relatively complex skill to learn, you could certainly learn this," Dr. Flowers said. The device also now has an improved inserter, which makes CyPass implantation more seamless, he added. "General ophthalmologists are afraid of extremely low pressures, but I haven't had that with the new inserter," Dr. Flowers said. One area getting mixed results is reimbursement. Some surgeons have had no problems, while others are still struggling. Dr. Sarkisian's billing team has received help from those at Alcon to achieve reimbursement for use of the device. EW Reference 1. Vold S, et al. Two-year COMPASS trial results: Supraciliary microstenting with phacoemulsification in patients with open-an- gle glaucoma and cataracts. Ophthalmology. 2016;123:2103–12. Editors' note: Dr. Craven and Dr. Sarkisian have financial interests with Alcon. Dr. Flowers and Dr. Nguyen have no financial interests related to their comments. Contact information Craven: ercraven@yahoo.com Flowers: bflowers@oafw2020.com The Chateaux Deer Valley Park City, Utah Interactive and engaging, with Q&A, video case presentations, a regulatory update by ASCRS, and panel discussions designed to provide you with valuable pearls and insights. Registration Now Open! View program updates and book housing at: SurgicalSummit.EyeWorld.org The 2018 Surgical Summit will be: CME EDUCATION ASCRS This activity is approved for AMA PRA Category 1 Credits.™ Questions? Contact SurgicalSummit@EyeWorld.org Join us at the Chateaux " This is a chance to interact personally with a number of really trusted and valued mentors. " — Louis Alpern, MD, El Paso, Texas

Articles in this issue

Links on this page

Archives of this issue

view archives of Eyeworld - JUL 2017